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Key points for the manuscript entitled “The impact of patient-centred versus didactic 
education programmes in chronic patients by severity. The case of Type 2 diabetes 
mellitus” 
 
What is already known about the topic?  
 Education improves health-related decisions and is an important component in 
preventative policy, especially for chronic patients.  
 Education programmes are mostly effective for chronic patients including 
diabetes type 2 patients. 
 The design of education programmes for chronic patients has to be cost effective 
within the transition towards chronic care systems that include the figure of the 
empowered patient. 
 
What does the paper add to existing knowledge?  
 Patient-centred education programmes are more effective than didactic 
education programmes for type 2 diabetes patients. 
 The difference in the benefits between patient-centred and didactic education 
programmes is not monotonic in the severity (measured by glycaemic control) of 
patients when initially diagnosed. 
 The benefits of attending the patient-centred programme relative to the didactic 
programme are significant for initially healthy patients, and also for severe 
patients; we find no difference in the benefits derived from both education 
programmes in patients with the worst glycemic control. 
 
What insights does the paper provide for informing health care-related decision 
making? 
 Preventative interventions such as patient-centred education programmes are 
effective for many patients but not enough for all of them. 
 In order to attain optimal and cost effective results, it is needed to develop a 
stratified health policy and find the most effective treatment and education 
programme for chronic patients depending on their severity, and other 
alternative interventions for most severe patients. 
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The impact of patient-centred versus didactic education programmes 
in chronic patients by severity. The case of type 2 diabetes mellitus. 
 
Abstract 
Objectives 
Education leads to better health-related decisions and protective behaviours. Patient 
self-management education programmes have been shown to be beneficial for patients 
with different chronic conditions, and to have a higher impact on health outcomes than 
didactic education. However, prior studies have not examined whether the initial 
severity of the condition is a factor affecting the relative impact of patients attending 
self-management and didactic education programmes.  
Methods 
We investigate improvements in glycemic control (measured by HbA1c) on a 
comparative trial on type 2 diabetes mellitus patients. Our comparative trial involves 
one group of type 2 diabetes patients receiving patient-centred education and another 
receiving didactic education. We deal with selection bias issues, estimate the different 
impact of both programmes and validate our analyiss using quantile regression 
techniques.  
Results 
We find evidence of better mean glycemic control in patients receiving the patient-
centred programme, which engages better patients compared to the didactic programme. 
However, that differential impact is non-monotonic. Patients initially at the healthy 
range and who receive the patient-centred programme maintain better their condition. 
Patients who are close to, but not within, the healthy glycemic range benefit equally 
from attending either programme.  Patients with very high glycemic level benefit 
significantly more from attending the patient-centred programme. Finally, patients with 
the worst initial glycemic control (far from the health range) improve equally their 
diabetes  condition, regardless of which programme they attended.  
Conclusions 
Different patients are sensitive to different categories of education programmes. The 
optimal, cost effective design of preventative programmes for chronics needs to account 
for the different impact in different ‘patient categories’. That implies that stratifying 
patients and providing the appropriate preventative education programme, or looking 
for alternative policy implementations for unresponsive patients who have the most 
severe condition and are most costly.  
 
Keywords: Patient-centred education; chronic disease self-management; quantile 
regression. 
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Introduction 
 
Education is a key input in the health production function [1]. It leads individuals to 
take better health-related decisions and more preventative behaviour in diet, exercise, 
and lifestyle, both for themselves [2,3,4,5] and for their children [6,7]. Empirical studies 
identify strong correlations between education background and health status [8,9,10], 
and between income levels and health status [11,12]. Education is especially important 
for chronic patients or individuals at risk of becoming chronic patients: they suffer (or 
are at risk of suffering) long-lasting conditions with persistent effects [13] that 
progressively diminish their quality of life, functional status and productivity [14,15]. 
Therefore, it is important for chronic patients to learn how to live with their conditions, 
or for individuals at risk to prevent them. Moreover, the way in which chronic 
conditions are prevented and treated is of  public concern as these currently account for 
more than 70% of health expenditures [16,17], are estimated to account for 70% of the 
global disease burden,  and will be responsible for 80% of deaths across the world by 
2030 [18,19].  
Patient self-management education programmes have been shown to be beneficial for 
patients with different chronic conditions, such as asthma [20], cardiac disease [21], 
chronic obstructive pulmonary disease [22], and type 2 diabetes [34, 35, 36, 37, 38]. 
They have the potential to make healthier patients’ lifestyle, improve their quality of 
life, and so, decrease the demand of health services provision and their health 
expenditures.  
In this paper we focus on education programmes for patients with diabetes mellitus 
(type 2 diabetes). Diabetes mellitus is a chronic disease in which the body fails to 
create, release and/or respond to insulin, resulting in hyperglycemia (raised blood sugar 
levels) and systemic damage to many areas of the body including the circulatory 
system, nervous system and internal organ damage. It is a major source of morbidity 
and mortality, estimated to affect globally to 9% among adults aged 18 or more [23]. 
Diabetes is responsible for enormous individual health costs related to direct and 
indirect effects of hyperglycemia on the human vascular tree. Its impact on patients’ life 
expectancy and health-related quality of life (HRQoL), depends on the severity and 
duration of hyperglycemia, i.e. the extent by which a person’s HbA1c blood sugar 
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levels lie outside the healthy range (4.0 to 7.0 mmol/l), and the length of time this 
occurs. In fact, the largest prospective, randomized study to date involving patients with 
type 2 diabetes (UKPDS35) [24] estimated that each 1% reduction in HbA1c reduces 
the risk of deaths related to diabetes by 21%, myocardial infarction by 14%, and 
microvascular complications by 37%. Other studies with data from the US [25,26,27] 
relate better glycemic control with fewer complications, hospital admissions, and lower 
health expenditures. 
Diabetes is a largely ‘self-managed’ condition. Day-to-day management is 
overwhelmingly in the hands of the patient, who must make long-term healthy lifestyle 
changes involving diet, exercise, and medication. Consequently, the quality of the 
diabetes education that patients receive shortly after initial diagnosis significantly 
influences their health choices, promoting the diet, exercise, and the lifestyle changes 
required to achieve and maintain healthy glycemic levels (i.e. within the 4.0 to 7.0 
mmol/l range).  
In patient-centred education, self-management plans are developed and maintained 
through collaboration between patients, who raise their concerns, priorities, knowledge 
and resources, and the clinical expertise of healthcare professionals. This definition of 
roles and responsibilities, between patient and healthcare professional, is claimed to 
increase the intrinsic motivation of diabetes patients to persistently follow agreed plans 
and attend medical checks [28,29,30,31]. This patient-centred approach is part of a 
wider shift in health policy for chronic care towards the ‘empowered patient’ model in 
many countries, and responds to rapidly rising diabetes-related health costs in national 
health systems [32,33].  
The didactic education model is very different. In the didactic model the patient is a 
passive recipient of standardized information, provided to all patients. The healthcare 
professional is an expert who prescribes and defines good practice in diet, exercise and 
lifestyle choices. Then, the passive patient is expected to adhere to the plans and 
prescriptions devised by the healthcare expert [34,28]. 
Hence, it is important to evaluate the impact of different education programmes for 
diabetic patients. It has been proposed that patient-centred education programmes for 
type 2 diabetes are more effective than didactic programmes in changing behaviour and 
ensuring compliance [35,36,37,38,39]. However, empirical evidence on their benefits is 
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mixed [36,37,40] and different issues have been raised about prior trials. First, they do 
not directly compare patient-centred and didactic programmes. Rather, control groups 
have consisted of patients receiving a mix of alternatives, or no formal education at all 
[37,40]. There might be selection bias since some trials include patients on medication 
to control their HbA1c. For those, reductions in recorded HbA1c may be due to 
teaching these patients how to take their prescriptions rather than improvements in diet, 
exercise and lifestyles. Second, the reporting period is many times too short. The 
literature finds [36] a difference in HbA1c between groups of 0.92% (p = 0.01) six 
months after the education programme. However, that period is generally considered 
too short of a period for permanent lifestyle changes to occur [40] and it is commonly 
agreed that using a reporting period of 12 or 18 months is preferable. Third, there are 
important differences in the patient-centred programmes in the trials, and there is a lack 
of consensus regarding the definition of patient-centred programme, its content, or its 
delivery [41]. 
Our trial study addresses all the above issues. Furthermore, a novel contribution of our 
analysis is the application of simultaneous quantile regression analysis. Previous 
research on diabetes education has not considered whether differential improvements in 
diabetes control vary across the patient distribution. There are a priori reasons to expect 
differentials to be non-monotonic. At one end of the distribution are patients who are 
healthy or close to the healthy glycemic range when initially checked and diagnosed. 
These may only need to make small lifestyle changes to improve their condition. At the 
other end are people with the worst health conditions (including obesity). They face the 
largest challenge in terms of making sustainable, long term changes to diet, exercise and 
lifestyle. Education programmes, regardless of category, might not have enough impact 
on these individuals to make them reach the healthy range. This paper contributes to the 
literature by examining the relative impacts of alternative education programmes across 
the patient distribution.  
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Methods 
The Salford Trial 
A total of 203 patients with type 2 diabetes were involved in the Salford trial. The trial 
group received a patient-centred programme; the control group, a didactic education 
programme. Issues of patient self-selection and General Practitioner (GP) selection were 
dealt with: in Salford, all patients diagnosed with type 2 diabetes are referred to a 
specialist education unit and receive a formal education programme within 1 month of 
diagnosis. In the trial period, patients were randomly selected to attend either the 
didactic or the patient-centred programme. Of the 203 patients in the trial, 109 received 
the didactic, and 94 the patient-centred programme. Other issues were taken into 
account. First, patients receiving medication to control their glycemic levels received 
education but were excluded from the trial. Second, all patients were drawn from the 
same set of six GP surgeries conforming the Salford Primary Care Trust to guarantee 
homogeneity in patients –the city of Salford is a poor socio-economic area with high 
unemployment, poor housing and social conditions, below national average education 
attainment, and overwhelmingly white, British ethnic background. Also, the same 
specialist education team delivered both programmes in the same number of sessions 
(three two-hours sessions held over three consecutive weeks) freely for patients, at a set 
of venues that are local to patients within Salford.  
In the didactic programme, medical specialists stand in front of the group and deliver 
the same presentation to all patients attending each session. The same information is 
provided to all patients who may raise questions. It is not tailored to individual patients. 
The content of the didactic course provides information on the causes of the condition 
and symptoms, information on diet and exercise, and foot care. Besides the verbally 
provided information, patients receive a set of leaflets freely available from the NHS 
and Diabetes UK. 
The Salford patient-centred programme is a ‘mediated learning’ approach based on 
learning sets applied to groups of 10 to 20 people. Healthcare professionals (trained in a 
2 day course) mediate discussions between patients on key areas of diabetes health and 
self-management. It delivers basic information so that patients can learn to use and 
critically appraise information on diabetes, how they can translate this information to 
their own individual circumstances, and learning how best to interact with other patients 
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who face the same set of issues as themselves. Importantly, patients also learn how to 
frame questions and engage in an open discourse with healthcare professionals 
mediating the programme. Consequently, patients gain confidence in voicing their 
concerns and interacting with healthcare professionals. This set of skills and 
experiences are not developed in the didactic education programme. The patient-centred 
programme is supported by an ‘education pack’ with the same basic information as in 
the didactic programme but its delivery is patient-centred, and patients are made to 
reflect on their own current behaviour and health choices. The pack is divided in three 
sections, with session specific material designed to be read by patients prior to each of 
them. This initiates the process of patient self-reflection prior to each of the relevant 
education sessions. Having read the supporting material, and having reflected upon it, 
patients use the materials as the basis for discussion in their group sessions. The patient-
centred programme finalizes with the drawing up of a personal ‘Action Plan’ with 
practical steps to change diet, exercise and lifestyle, and the key goals which they will 
strive to achieve, supervised by the GP.  
The difference in marginal costs between the two programmes is small and depends on 
two components. First, the cost of printed materials provided to patients, which was of 
£2.00 per pack for the patient-centred programme while in the didactic programme were 
provided free of charge to the Salford Diabetes Education Team by the NHS and 
Diabetes UK. Second, the patient-centred programme included a two-day training 
course for the education team in the mediated learning approaches that underpin the 
patient-centred programme. The opportunity cost for the two days, based on the wages 
of the Salford Diabetes Education Team, was £2211.00 (the annual salary of the Team 
Leader was £51,718 -NHS Band 8B-, the average wage of ten nurses, dieticians and 
podiatrists was £35,184 -NHS Bands 6 and 7-, and the team administrator wage is 
£20,804). For the 94 patients attending the patient-centred education programme, the 
additional cost per patient is £26.00. It is important to note that these marginal costs fall 
over time, as more patients receive the patient-centred programme, to the limit of £2.00 
per patient (i.e. the differential cost of printed materials) when we adopt the perspective 
of the Salford Diabetes Education Team, or to zero when we consider the societal 
perspective (under which we take into account that the NHS and Diabetes UK have still 
to assume the cost of the printed materials for individuals in the didactic programme 
and that it was equally of £2.00 per pack). 
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Dataset 
For each of the 203 patients there are two fasting HbA1c scores recorded by the 
patients’ GPs (406 observations): HbA1c_Month0 is the fasting glucose level recorded 
when the patient was first diagnosed with type 2 diabetes. It indicates the patient’s 
diabetes control prior to receiving one or other education intervention. HbA1c_Month12 
is recorded 12 months after diagnosis, as part of the patient’s annual diabetes check-up. 
It indicates the patient’s diabetes control 12 months after the education programme. The 
dataset includes three demographic variables that are standard control variables: age of 
the patient at the time they attend the education programme; gender (indicated by the 
dummy variable female), and ethnic background (indicated by the dummy variable 
white_eur). 
Table 1 provides descriptives for the variables in the dataset. There are no statistically 
significant differences in gender, age, or ethnicity of patients attending the two 
education programmes. Difference in mean female representation in the patient-centred 
and didactic groups is -0.03 (54% and 57% in the patient-centred and didactic groups 
respectively). With respect to age, the mean difference between the patient-centred and 
didactic groups is the same (65.35 with SD: 8.45 in the didactic and 65.8 with SD: 9.69 
in the patient-centred). Regarding ethnicity, the means and standard deviations for white 
European ethnicity are identical because Salford residents are overwhelmingly white 
European. 
The difference of 0.01 mmol/l (at the 5% level) between the mean HbA1c_Month0 
scores of patients in both programmes is non-significant: 7.759 mmol/l (SD: 1.621) in 
the patient-centred and 7.749 mmol/l (SD: 1.629) in the didactic, with t = -0.0438 and t 
= -0.0439 for the two-sample t test with equal and unequal variances respectively 
(critical t0.05; 203 = 1.9718). However, after 12 months, there is a significant difference in 
HbA1c_Month12 scores of -0.325 mmol/l, lower for patients attending the patient-
centred programme, at the 5% level: 6.838 mmol/l (SD: 0.859) in the patient-centred 
and 7.163 mmol/l (SD: 1.009) in the didactic programme, with t = -2.4479 and t = -
2.4770 for the two-sample t test with equal and unequal variances respectively (critical 
t0.05; 203 = -1.9718). 
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In terms of individual and social costs, the estimated mean differences are highly 
important. The mean glycemic control of the patient-centred education group is at the 
upper limit of the healthy glycemic range in month 12 (6.838 mmol/l) while for the 
didactic education group it is above that upper limit (7.163 mmol/l). The median score 
is within the healthy range in both groups although lower for the patient-centred group 
than for the didactic (6.6 and 6.8 mmol/l respectively). At the same time, the maximum 
value found in month 12 within patients in the patient-centred group is of 9.3 mmol/l 
compared to 11.5 mmol/l in the didactic group, which means that the worst patients 
behave better in the patient-centred than the didactic group, although all of them are still 
far from the healthy range. 
We observe large differences in the within-group changes recorded in months 0 and 12. 
A 0.7 mmol/l reduction is recorded in the median scores of the patient-centred group 
(month 12 = 6.6 mmol/l; month0 = 7.3 mmol/l). while this reduction is of 0.6 mmol/l 
reduction in the median scores of the didactic group (month 12 = 6.7 mmol/l; month0 = 
7.4 mmol/l). This difference increases in the distribution for patients with worse 
glycemic control, being of 1.2 mmol/l and 0.6 mmol/l at the 75
th
 percentile (month 12 = 
7.5 mmol/l; month 0 = 8.7 mmol/l for the patient-centred group; and month 12 = 7.9 
mmol/l; month 0 = 8.5 mmol/l for the didactic group), and of 4.8 mmol/l and 2.9 mmol/l 
at the maximum value or worst glycemic control patient (month 12 = 9.3 mmol/l; month 
0 = 14.1 mmol/l for the patient-centred group; and month 12 = 11.9 mmol/l; month 0 = 
14.4 mmol/l for the didactic group). We also observe a notable difference in the 
estimated mean scores. Subject to rounding errors, the mean difference-in-difference 
(DD) improvement in glycemic control, over 12 months, for the average patient 
attending the patient-centred programme, compared to the average patient attending the 
didactic programme, is 0.335 mmol/l (calculated as [7.759 - 6.838] – [7.749 - 7.163]). 
Table 1 also offers the same statistics for the pooled sample with patients attending both 
patient-centred and didactic education programmes, with N=203. 
[Table 1] 
 
Figure 1 provides quantile plot graphs of the distributions of HbA1c_Month0 and 
HbA1c_Month12 scores for both groups of patients including the normal (Gaussian) 
distribution on the diagonal line. These distributions are not right skewed but have tails 
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that lie above the diagonal line. Therefore, the distribution matters for the effect of 
education and deviations from normality lie closer to the centre of the distribution.  
 
[Figure 1] 
 
 
Estimation analysis 
We apply OLS estimation strategy with fixed effects to test whether there is a statistical 
difference in the mean improvement in HbA1c control (month12 – month0) of patients 
attending the patient-centred programme relative to those attending the didactic 
programme (pc – didactic). The estimated statistical model is:  
   (1) 
where the dependent variable Diff(HbA1c) is the total set of 203 observations with the 
difference in the blood score at month 0 minus the blood score taken at month 12 for 
each individual. Our variable of interest is the dichotomous variable 

pci  (patient-
centred programme) that takes value 1 when the patient has attended the patient-centred 
programme and 0 if he has attended the didactic programme. Older than 65 and female 
are demographic variables, and 

  is the white noise error term.  
A key issue not explored in prior research in diabetes education studies is whether the 
impact of different education programmes varies across the patient distribution. We 
estimate, as a robustness check, an OLS model containing a set of dummy variables 
(equation 2) with coefficients for different ranges depending on the initial glycemic 
level (IG(1)i=1 at the healthy range when blood score at month 0 is lower than 7 
mmol/l; IG(2)i=1 when it was high but close to the healthy range when blood score was 
between 7 and 8.5 mmol/l, IG(3)i=1 at very high initial glycemic level, when it was 
between 8.5 and 10 mmol/l; and IG(4)i=1 at catastrophic initial glycemic level, when 
blood score was greater than 10 mmol/l at month 0). In this estimation, we will be 
interested in the coefficients (𝛿) for the interactions between patient-centred programme 
and the initial glycemic levels. 
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(2) 
Applying simultaneous quantile regression methods, one can consider, the differential 
impact on diabetes control of the patient-centred programme at individual points over 
the conditional patient distribution..  
Quantile methods are appropriate where distributions are non-Gaussian or, as here, 
where there is heterogeneity between segments of the analysed conditional distribution 
[42]. Quantile regression is a semi-parametric method. The conditional quantile has a 
linear form but does not impose a set of assumptions regarding the conditional 
distribution, and minimizes the weighted absolute deviations to estimate conditional 
quantile (percentile) functions [43,44]. For the median (0.5 percentile), symmetric 
weights are used. For all other percentiles (e.g., 0.1, 0.2, ..., 0.9) asymmetric weights are 
employed. By contrast, classical OLS regression minimises the sums of squared 
residuals in order to estimate models for conditional mean functions.  
Quantile regression is preferable to the alternative of segmenting the dependent variable 
into subsets according to its unconditional distribution and then applying OLS on the 
subsets because such truncation of the dependent variable can create biased parameter 
estimates [45]. Because quantile regression employs the full dataset, the sample 
selection problem does not arise. We deal with the issue of heteroskedacity in standard 
errors using Gould’s bootstrapping procedure [46,47]. Standard errors are obtained via 
1000 replications of a panel bootstrap. This is drawn using a fixed initial seed (i.e. 
1000), with each individual bootstrapped sample containing the same number of 
observations as the original sample (i.e. 109 for the didactic and 94 for the patient-
centred samples). The software used in all our estimations is Stata 12
1
. 
 
Results 
Table 2 presents the estimated coefficients for our first model. The constant being 
negative and significant (constant = -0.709; p=0.001), the effect of any type of 
education is, on average, positive with a fall in HbA1c scores indicating improved 
                                                        
1 http://www.stata.com/stata12/  
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glycemic control twelve months after receiving education. Notably, estimated OLS 
coefficient is -0.338 mmol/l (p=0.076) indicating that, on average, patients attending the 
patient-centred programme better control their diabetes after receiving their programme 
than control patient group who received a didiactic education programme.  
 
Table 2 also provides information on estimated simultaneous quantile regression models 
at the 25
th
, 50
th
 and 70
th
 percentiles. In these estimated models, the estimated coefficient 
is negative but is significant only for the 50
th
 and 70
th
 percentiles (-0.299 mmol/l 
(p=0.041), and -0.199 mmol/l (p=0.077) respectively). This indicates that net gains are 
non-monotonic.  
Age and gender tend not to be statistically significant in the estimated OLS and quantile 
models in Table 2. This is in line with previous random control trials. 
 
[Table 2] 
 
In order to investigate this further, we estimate an OLS model that contains a set of 
dummy variables for different ranges of initial glycemic level (healthy, high but close to 
healthy, very high, and extreme). In this way, one can take into account the initial 
condition of patients when entering one or other education programme. We estimate the 
different effect of patient-centred versus didactic education programmes for each range, 
through the interaction of these dummies and their attendance of one or other 
programme. Estimates are provided in Table 3a. For individuals within the healthy 
range, the intercept is not significant, but the patient-centred programme is significantly 
more beneficial than the didactic programme, with a coefficient of -0.572 (p=0.014). 
For all other ranges of initial glycemic control, with HbA1c greater than 7 mmol/l (high, 
very high and extreme), the intercept is negative, statistically significant and increasing 
(-0.495 with p=0.004; -1.293 with p=0.000; and -3.643 with p=0.000).  
These results also indicate that education is increasingly beneficial in the initial level of 
HbA1c in mmol/l, whilenet difference in the glycemic control of patients receiving a 
patient-centred education relative to those receiving a didactic programme is non-
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monotonic and depends on their initial condition. For individuals with high initial 
HbA1c but close to the healthy range (7 to 8.5 mmol/l), both programmes are equally 
effective (i.e. the estimated coeffcieint is not statistically significant). However, for 
individuals with a very high HbA1c initial level (between 8.5 and 10 mmol/l), the 
patient-centred program is more effective in improving the glycemic control than the 
didactic programme with a coefficient of -0.490 (p=0.083). Finally, for individuals with 
an extreme initial HbA1c level (greater than 10 mmol/l), there is aso no statistical 
difference in glycemic control of patients receiving either programme..  
These results are consistent with the predicted difference (Month 0 - Month 12) in the 
blood scores for the patient-centred compared to the didactic programme shown in 
Figure 2a, with significant differences at the healthy initial range and also at the third 
range of very high HbA1c initial level. In the case of the patient-centred programme, 
the predicted difference is always negative (beneficial) while for the didactic 
programme it is not.  
In order to understand the different effectiveness among both programmes is useful to 
look at the 35 individuals (8 in the patient-centred and 27 in the didactic) for which the 
programme has not produced any benefit and their glycemic control has worsened 
(Figure 2b). For them, the average difference is of 0.425 (patient-centred) and 0.837 
(didactic), and is significant for those individuals at the healthy initial range and the 
only range of initial HbA1c in which individuals at the patient-centred programme 
worsen more than those at the didactic programme is between 7 and 8.5 mmol/l. Once 
again, age and gender are not found to be statistically significant.  
Table 3b presents the percentage of success, by education programme, in patients 
achieving a healthy glycemic range after 12 months.The most significant differences are 
for individuals in the healthy initial level and for those with initial glycemic level 
between 8.5 and 10 mmol/l. 
 
[Table 3a and Table 3b] 
 
[Figure 2a and 2b] 
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In order to explore more extensively the different effectiveness of both programmes 
across the distribution, a set of simultaneous quantile regression models were estimated 
at 0.05 percentile intervals, from the .05 to the .95 percentile. Table 4 reports the 
coefficients for the intercept and the patient-centred differential effect for such models 
(demographic variables were included but not reported as they were mostly non-
significant). Results are consistent with our previous estimations. However, it is 
important to note that, where in the OLS analysis we ascertained the average 
improvement effects for individuals who started with different glycemic control levels, 
with the quantile regression we can examine the effects on the q-quantile itself.  
We find a non-monotonic relationship across the patient distribution. In the first half of 
the HbA1c distribution , the difference between the blood scores at Month 0 and 12 is 
mostly explained by the intercept, which is negative, large, and statistically significant 
(percentiles 0.05 to 0.50). The differential between effect of the patient-centred 
programme is negative but non-significant.  
Progressing further along the distribution (percentiles 0.50 to 0.90), the differential 
becomes larger and the effect of education is more often explained by attendance of a 
specific programme than by the intercept (the receiving of education in general). This 
indicates that there is a strong effect due to the patient-centred programme for patients 
within this range.  
 
[Table 4] 
 
Figure 3 shows the coefficients for the intercept and differential effect of the patient-
centred programme across the distribution. We see that the net difference in glycemic 
control is always negative and mostly significant (95% CI) between 50
th
 and 90
th
 
percentiles of the distribution. However, the difference is non-monotonic, decreasing in 
absolute value between the 50
th
 percentile (-0.300;  p=0.041) and the 70
th
 percentile (-
0.200; p=0.077). Above the 70
th
 percentile, the differential increases up to the 90
th
 
percentile (-0.400 with p=0.042), after which the estimated differential becomes non-
significant for the remainder of the HbA1c distribution.  
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[Figure 3] 
 
Conclusions 
Education leads individuals to take better health-related decisions and more 
preventative behaviour. Education is thus an important component in preventative 
health policy, especially for patients with chronic conditions such as diabetes. In this 
paper we consider two categories of education programmes designed to promote 
behavioural change to healthier lifestyles amongst people with type 2 diabetes, and 
thereby prevent or reduce significantly the severity of the complications associated with 
this condition. In contrast with COPD, cardiac disease, asthma, and type 1 diabetes 
where there is strong evidence of a relationship between education and improved health 
outcomes [20,21,22], empirical evidence for type 2 diabetes is mixed [36,37,40].  
The empirical results clearly indicate improvements in the mean glycemic control of 
patients receiving the patient-centred programme after 12 months compared to patients 
receiving the didactic programme. Based on a well-specified control group, the average 
effect estimated by OLS is -0.338 mmol/l, at the upper end of previous trials reported in 
the meta-studies [37,40]. This level of improved metabolic control represents a 
significant reduction in complications, and improvement in quality of life.  
By also applying OLS at different ranges of the glycemic level and quantile regression 
methods, the current study sheds new light on the effectiveness of education 
programmes. In particular, it has identified four distinct categories of patient within the 
diabetes population. 
Based on the findings of our study, patients initially at the healthy range need to 
understand their condition and undertake preventive measures to avoid future 
complications. For them, patient-centred education is significantly more effective than 
the didactic programme. In fact, the didactic programme is not effective for those 
patients as in average they worsen their glycemic control. Hence, healthy patients are 
not engaged in the didactic programme, do not take seriously education and do not 
prevent. They should attend patient-centred education. Second, patients with high 
glycemic level but close to the healthy range are able to make changes in their lifestyles 
within 12 months. For them, any education programme is effective and benefitial 
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compared to the alternative of no education. Although results are better for the patient-
centred programme the difference is not significant, probably because being close to the 
healthy range, but already unhealthy, patients enrolled in any program obtain a high rate 
of success. Third, patients with very high glycemic level need specific education to 
contribute to their behavioural change. Being far from the healthy glycemic level, 
engaging patients becomes more important and our findings suggest that, for this 
category of patient, again, patient-centred education is more effective than didactic 
education. Finally, for patients with the worst health conditions, including obesity, and, 
as a consequence, the highest individual health costs, we find that patients receiving 
patient-centred education do not benefit more than patients receiving didactic education. 
For this category of patient, aware of his need, both patient-centred and didactic 
preventative education programmes are very effective in changing lifestyles and 
improving health choices, and all of them improve their glycemic control even if most 
of them do not get to the healthy range in 12 months. 
Our research findings highlight the need for a stratified health policy. Preventative 
health policy can be effective for most patients at initially healthy, high or very high 
glycemic level, and the patient-centre programme presents better results. Our results 
presents several limitations. First, they are based on our case study with a sample size of 
203 individuals. As a consequence, in order to generalize our results and policy 
recommendations for education programmes, they should be confirmed by similar 
studies. Also, the focus in our paper is not to develop a full cost effectiveness analysis 
of the two education programmes. However, prior work on the economic evaluation of 
diabetes education programmes [48], literature relating improvement in the control of 
glycemic levels and a lower demand of health services and expenditures [24,25,26,27], 
and the minimum additional cost per patient (£26.00) of the patient-centred programme 
point to significant savings in health expenditures for patients in the relatively healthy 
and intermediate categories at the initial diagnose attending to the patient-centred 
programme.  
However, for the last patient category – made up of patients with the most severe 
condition - education is effective in improving glycemic control but not in getting 
patients into the healthy range, and guidelines are required for finding their most 
effective treatment or complement to education. This may include alternative 
interventions such as bariatric surgical procedures (gastric banding, gastric bypass, or 
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sleeve gastrectomy). The cost-benefit implications for health expenditure of surgical 
procedures such as these are different to preventative health education programmes. 
Although further research is needed in this topic, our results point to policy stratification 
as a requirement to achieve an optimal resource allocation, which produces the correct 
mix of education and other health interventions to different patient categories.  
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Table 1. Means, standard deviations, minimum and maximum values, 25th percentile, 
median and 75th percentile.  
 
  
Didactic 
group 
Patient-centred 
group 
Pooled 
sample 
HbA1c_Month0 
(mmol/ l) 
Mean 7.749 7.759 7.754 
Std. Deviation 1.629 1.621 1.621 
Minimum 5.4 5.5 5.4 
25th perc.  6.7 6.6 6.6 
Median       7.4 7.3 7.3 
75th perc.             8.5 8.7 8.6 
Maximum 14.4 14.1 14.4 
HbA1c_Month12 
(mmol/ l) 
Mean 7.163 6.838 7.012 
Std. Deviation 1.009 0.859 0.954 
Minimum 5.6 5.3 5.3 
25th perc.  6.4 6.3 6.4 
Median       6.8 6.6 6.7 
75th perc.  7.9 7.5 7.7 
Maximum 11.5 9.3 11.5 
Age 
Mean 65.35 65.35 65.35 
Std. Deviation 8.45 9.69 9.05 
Female 
Mean 0.54 0.57 0.55 
Standard 
Deviation 0.5 0.49 
0.49 
White_eur 
Mean 0.99 0.99 0.99 
Std. Deviation 0.1 0.1 0.1 
N   109 94 203 
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Table 2. OLS and quantile regressions on the difference between HbA1c scores of 
patients attending the patient-centred programme and the control group attending the 
didactic programme.  
Dependent Variable: Difference between the HbA1c blood scores (mmo/l) in Month 0 
and Month 12 
  OLS  25
th
 percentile 50
th
 percentile 70
th
 percentile 
  Coefficent 
Robust 
S.E. 
Coefficent 
Robust 
S.E. 
Coefficent 
Robust 
S.E. 
Coefficent 
Robust 
S.E. 
Patient-centred 
programme 
(differential impact 
relative to didactic 
programme) 
   
- 4.77e-07 (0.387)  - 0.299** (0.145) - 0.199* (0.112) 
 - 0.338* (0.189) 
                  
Control variables:                 
Female 0.157 (0.192) 0.500 (0.372) 0.299* (0.163) 1.09e-19 (0.226) 
Older than 65 0.052 (0.192) 0.200 (0.338) 0.199 (0.232) 7.42e-17 (0.161) 
                  
Constant - 0.709*** (0.207) - 1.600*** (0.356) - 0.599*** (0.873) - 2.36e-16 (0.172) 
                  
N   203 203 203 203 
F   1.18       
R
2
   0.0185       
Pseudo R
2
     0.0148 0.0180 0.0090 
 *** p<.01; ** p<.05; * p<.10    Quantile bootstrap reps = 1000. 
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Table 3a. OLS estimation of the effect of patient-centred programme relative to the 
didactic programme in the variation of HbA1c blood scores by initial glycemic level. 
 
 Dependent Variable: Difference (Month 0 – Month 12) in the HbA1c blood scores 
(mmol/l)  
  
Coefficient Std. Error P>|t| 
Constant by range of IG       
  IG(1): Initial HbA1c < 7 mmol/l 0.182 0.231 0.430 
  IG(2): 7.0 mmol/l ≤ Initial HbA1c < 8.5 mmol/l -0.495*** 0.169 0.004 
  IG(3): 8.5 mmol/l ≤  Initial HbA1c < 10 mmol/l -1.293*** 0.195 0.000 
  IG(4): Initial HbA1c ≥ 10 mmol/l -3.643*** 0.411 0.000 
Differential effect  
(Patient-centred  relative to didactic programme)       
  IG(1)*patient-centred -0.572** 0.231 0.014 
  IG(2)*patient-centred -0.053 0.180 0.769 
  IG(3)*patient-centred -0.490* 0.281 0.083 
  IG(4)*patient-centred -0.044 0.585 0.940 
Demographic variables       
  Older than 65 0.085 0.135 0.532 
  Female 0.094 0.127 0.458 
      
N   203 
R-squared 0.6847 
*** p<.01; ** p<.05; * p<.10  
IG: Initial Glycemic level 
 
Table 3b. Percentage of patients within the healthy glycemic range by Month 12, 
according to initial glycemic level (IG). 
 
Patient-centred Didactic 
IG(1): Initial HbA1c < 7 mmol/l 100.00% 88.57% 
IG(2): 7.0 mmol/l < Initial HbA1c < 8.5 mmol/l 62.96% 56.52% 
IG(3): 8.5 mmol/l <  Initial HbA1c < 10 mmol/l 47.37% 22.22% 
IG(4): Initial HbA1c > 10 mmol/l 22.22% 20.00% 
IG: Initial Glycemic level 
  
 25 
Table 4. Estimates of the differential improvement in glycemic control of patients 
attending patient-centred compared to those attending didactic programmes, and 
intercept in the simultaneous quantile regressions: Distribution 5% to 95%. 
 
Differential  
(Patient-centred relative to 
didactic programme) Intercept 
Percentile Coefficient Std. Error P>|t| Coefficient Std. Error P>|t| 
0.05 -1.300 0.922 0.160 -2.000** 0.977 0.042 
0.1 -0.600 0.575 0.298 -1.900*** 0.572 0.001 
0.15 -0.300 0.488 0.539 -1.900*** 0.406 0.000 
0.2 0.000 0.454 1.000 -1.700*** 0.380 0.000 
0.25 0.000 0.388 1.000 -1.600*** 0.357 0.000 
0.3 -0.100 0.300 0.740 -1.300*** 0.333 0.000 
0.35 -0.200 0.228 0.381 -1.100*** 0.295 0.000 
0.4 -0.200 0.198 0.313 -0.800*** 0.247 0.001 
0.45 -0.200 0.177 0.261 -0.700*** 0.184 0.000 
0.5 -0.300** 0.145 0.041 -0.600*** 0.142 0.000 
0.55 -0.200 0.123 0.106 -0.500*** 0.143 0.001 
0.6 -0.300*** 0.113 0.009 -0.400** 0.172 0.021 
0.65 -0.200* 0.113 0.079 -0.200 0.189 0.290 
0.7 -0.200* 0.112 0.077 0.000 0.173 1.000 
0.75 -0.100 0.112 0.375 0.000 0.153 1.000 
0.8 -0.200* 0.111 0.073 0.200 0.150 0.185 
0.85 -0.300** 0.116 0.011 0.300* 0.156 0.056 
0.9 -0.400** 0.195 0.042 0.500* 0.284 0.080 
0.95 -0.800 0.685 0.244 1.000 0.811 0.219 
*** p<.01; ** p<.05; * p<.10  
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Figure 1. Quantile plots of initial HbA1c scores (in mmol/l) when receiving an 
education programme (HbA1c_Month0) and 12 months after programme 
(HbA1c_Month12).  
 
  
(a) Didactic distribution HbA1c_Month0 (b) Didactic distribution HbA1c_Month12 
  
(c) Patient-centred distribution HbA1c_Month0 (c) Patient-centred distribution HbA1c_Month12 
 
N=203 (109 in the Didactic programme and 94 in the Patient-Centred programme). 
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Figure 2a: Predicted difference in the blood score (in mmol/l) for individuals 
receiving either the patient-centred or the didactic programme. 
 
Figure 2b: Predicted difference in the blood score (in mmol/l) for individuals 
worsening their glycemic control (Month 0 – Month 12) at both the patient-
centred and the didactic programme. 
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Figure 3. Percentile distribution of the intercept and differential impact of the patient-
centred relative to the didactic programme in simultaneous quantile regressions.  
Dependent variable: difference in HbA1c blood scores (Month 0 – Month 12).  
 
 
 
